India’s Draft Plan To End API Reliance On China ‘Needs Work’

India has come up with a draft policy proposal to end the dependence of the country’s generic drug industry on Chinese bulk drug imports but it’s sketchy on measures, at least so far, to promote domestic production and “needs work.”

Pills
INDIA AIMS TO LOWER ITS DEPENDENCE ON CHINESE APIs

Back in January 2016, the government set a 2020 deadline to end the country's heavy dependence on neighboring China for raw materials to make medicines, especially key antibiotics and painkillers, and it announced ambitious plans to ramp up production of bulk drugs.

[Sidebar#SC089232]

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from India

More from Asia